York Charles N II, COO and CFO of Day One Biopharmaceuticals ($DAWN), sold shares on the open market four times in the last 365 days for a total of about $161 thousand. His most recent sale occurred on February 17, 2026. These sales rank in 8,852nd place among 11,678 individual insiders, compared to an average sale value of $8.6 million across about six transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 46,375.0000 | 103,381,315 | 12.50% | 0.01% |
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 6,750.0000 | 103,381,315 | 25.00% | 0.00% |
| Feb. 17, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | S | Common Stock | 6065 | $11.60 | 312,025.0000 | 103,381,315 | 1.91% | 0.01% |
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 7875 | $0.00 | 318,090.0000 | 103,381,315 | 2.54% | 0.01% |
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 6625 | $0.00 | 310,215.0000 | 103,381,315 | 2.18% | 0.01% |
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 6625 | $0.00 | 303,590.0000 | 103,381,315 | 2.23% | 0.01% |
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 2250 | $0.00 | 296,965.0000 | 103,381,315 | 0.76% | 0.00% |
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 7875 | $0.00 | 118,125.0000 | 103,381,315 | 6.25% | 0.01% |
| Feb. 15, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 72,875.0000 | 103,381,315 | 8.33% | 0.01% |
| Jan. 30, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | A | Restricted Stock Units | 126000 | $0.00 | 126,000.0000 | 103,381,315 | 9999.99% | 0.12% |
| Jan. 30, 2026 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | A | Stock Option (right to buy Common Stock) | 188000 | $0.00 | 188,000.0000 | 103,381,315 | 9999.99% | 0.18% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 6625 | $0.00 | 292,152.0000 | 103,381,315 | 2.32% | 0.01% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 6625 | $0.00 | 298,777.0000 | 103,381,315 | 2.27% | 0.01% |
| Nov. 17, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | S | Common Stock | 4062 | $8.91 | 294,715.0000 | 103,381,315 | 1.36% | 0.00% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 1375 | $0.00 | 283,277.0000 | 103,381,315 | 0.49% | 0.00% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 9,000.0000 | 103,381,315 | 20.00% | 0.00% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 53,000.0000 | 103,381,315 | 11.11% | 0.01% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 79,500.0000 | 103,381,315 | 7.69% | 0.01% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 0.0000 | 103,381,315 | 100.00% | 0.00% |
| Nov. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 2250 | $0.00 | 285,527.0000 | 103,381,315 | 0.79% | 0.00% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | A | Stock Option (right to buy Common Stock) | 162000 | $0.00 | 162,000.0000 | 103,381,315 | 9999.99% | 0.16% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | A | Stock Option (right to buy Common Stock) | 162000 | $0.00 | 162,000.0000 | 103,381,315 | 9999.99% | 0.16% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | D | Stock Option (right to buy Common Stock) | 162000 | $0.00 | 0.0000 | 103,381,315 | 100.00% | 0.16% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | A | Stock Option (right to buy Common Stock) | 116000 | $0.00 | 116,000.0000 | 103,381,315 | 9999.99% | 0.11% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | D | Stock Option (right to buy Common Stock) | 116000 | $0.00 | 0.0000 | 103,381,315 | 100.00% | 0.11% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | A | Stock Option (right to buy Common Stock) | 151000 | $0.00 | 151,000.0000 | 103,381,315 | 9999.99% | 0.15% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | D | Stock Option (right to buy Common Stock) | 151000 | $0.00 | 0.0000 | 103,381,315 | 100.00% | 0.15% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | A | Stock Option (right to buy Common Stock) | 497667 | $0.00 | 497,667.0000 | 103,381,315 | 9999.99% | 0.48% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | D | Stock Option (right to buy Common Stock) | 497667 | $0.00 | 0.0000 | 103,381,315 | 100.00% | 0.48% |
| Nov. 6, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | D | Stock Option (right to buy Common Stock) | 162000 | $0.00 | 0.0000 | 103,381,315 | 100.00% | 0.16% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 59,625.0000 | 93,234,195 | 10.00% | 0.01% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 11,250.0000 | 93,234,195 | 16.67% | 0.00% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 1,375.0000 | 93,234,195 | 50.00% | 0.00% |
| Aug. 18, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | S | Common Stock | 4106 | $6.77 | 278,000.0000 | 93,234,195 | 1.46% | 0.00% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 6625 | $0.00 | 282,106.0000 | 93,234,195 | 2.40% | 0.01% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 1375 | $0.00 | 266,606.0000 | 93,234,195 | 0.52% | 0.00% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 6625 | $0.00 | 275,481.0000 | 93,234,195 | 2.46% | 0.01% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Common Stock | 2250 | $0.00 | 268,856.0000 | 93,234,195 | 0.84% | 0.00% |
| Aug. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO and CFO | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 86,125.0000 | 93,234,195 | 7.14% | 0.01% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 262,888.0000 | 93,234,195 | 2.59% | 0.01% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 1375 | $0.00 | 254,013.0000 | 93,234,195 | 0.54% | 0.00% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 2250 | $0.00 | 256,263.0000 | 93,234,195 | 0.89% | 0.00% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 269,513.0000 | 93,234,195 | 2.52% | 0.01% |
| May 16, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 4282 | $6.26 | 265,231.0000 | 93,234,195 | 1.59% | 0.00% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 2,750.0000 | 93,234,195 | 33.33% | 0.00% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 13,500.0000 | 93,234,195 | 14.29% | 0.00% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 66,250.0000 | 93,234,195 | 9.09% | 0.01% |
| May 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 92,750.0000 | 93,234,195 | 6.67% | 0.01% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 99,375.0000 | 93,234,195 | 6.25% | 0.01% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 1375 | $0.00 | 241,508.0000 | 93,234,195 | 0.57% | 0.00% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 2250 | $0.00 | 243,758.0000 | 93,234,195 | 0.93% | 0.00% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 250,383.0000 | 93,234,195 | 2.72% | 0.01% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 257,008.0000 | 93,234,195 | 2.65% | 0.01% |
| Feb. 18, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 4370 | $11.96 | 252,638.0000 | 93,234,195 | 1.70% | 0.00% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 4,125.0000 | 93,234,195 | 25.00% | 0.00% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 15,750.0000 | 93,234,195 | 12.50% | 0.00% |
| Feb. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 72,875.0000 | 93,234,195 | 8.33% | 0.01% |
| Jan. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | A | Stock Option (right to buy Common Stock) | 162000 | $0.00 | 162,000.0000 | 93,234,195 | 9999.99% | 0.17% |
| Jan. 15, 2025 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | A | Restricted Stock Units | 106000 | $0.00 | 106,000.0000 | 93,234,195 | 9999.99% | 0.11% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 18,000.0000 | 96,937,759 | 11.11% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 1375 | $0.00 | 233,860.0000 | 96,937,759 | 0.59% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 2250 | $0.00 | 236,110.0000 | 96,937,759 | 0.96% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 242,735.0000 | 96,937,759 | 2.81% | 0.01% |
| Nov. 18, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 2602 | $13.21 | 240,133.0000 | 96,937,759 | 1.07% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 5,500.0000 | 96,937,759 | 20.00% | 0.00% |
| Nov. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 79,500.0000 | 96,937,759 | 7.69% | 0.01% |
| Aug. 16, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 2633 | $14.00 | 232,485.0000 | 79,773,004 | 1.12% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 86,125.0000 | 79,773,004 | 7.14% | 0.01% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 20,250.0000 | 79,773,004 | 10.00% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 6,875.0000 | 79,773,004 | 16.67% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 235,118.0000 | 79,773,004 | 2.90% | 0.01% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 2250 | $0.00 | 228,493.0000 | 79,773,004 | 0.99% | 0.00% |
| Aug. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 1375 | $0.00 | 226,243.0000 | 79,773,004 | 0.61% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 22,500.0000 | 79,773,004 | 9.09% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 1375 | $0.00 | 218,668.0000 | 79,773,004 | 0.63% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 2250 | $0.00 | 220,918.0000 | 79,773,004 | 1.03% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 227,543.0000 | 79,773,004 | 3.00% | 0.01% |
| May 16, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 2675 | $16.08 | 224,868.0000 | 79,773,004 | 1.18% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 8,250.0000 | 79,773,004 | 14.29% | 0.00% |
| May 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 92,750.0000 | 79,773,004 | 6.67% | 0.01% |
| May 1, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 52183 | $17.89 | 225,571.0000 | 79,773,004 | 18.79% | 0.07% |
| May 3, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 8078 | $17.85 | 217,293.0000 | 79,773,004 | 3.58% | 0.01% |
| May 2, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 200 | $17.90 | 225,371.0000 | 79,773,004 | 0.09% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 2250 | $0.00 | 24,750.0000 | 79,773,004 | 8.33% | 0.00% |
| Feb. 16, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | S | Common Stock | 2666 | $15.25 | 277,754.0000 | 79,773,004 | 0.95% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 6625 | $0.00 | 280,420.0000 | 79,773,004 | 2.42% | 0.01% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 2250 | $0.00 | 273,795.0000 | 79,773,004 | 0.83% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Common Stock | 1375 | $0.00 | 271,545.0000 | 79,773,004 | 0.51% | 0.00% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 6625 | $0.00 | 99,375.0000 | 79,773,004 | 6.25% | 0.01% |
| Feb. 15, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO AND SECRETARY | M | Restricted Stock Unit (RSU) | 1375 | $0.00 | 9,625.0000 | 79,773,004 | 12.50% | 0.00% |
| Jan. 5, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO and Secretary | A | Restricted Stock Units | 106000 | $0.00 | 106,000.0000 | 79,773,004 | 9999.99% | 0.13% |
| Jan. 5, 2024 | Day One Biopharmaceuticals, Inc. | $DAWN | York Charles N II | COO, CFO and Secretary | A | Stock Option (right to buy Common Stock) | 162000 | $0.00 | 162,000.0000 | 79,773,004 | 9999.99% | 0.20% |